Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000273949 | SCV000373327 | uncertain significance | Neuronal Ceroid-Lipofuscinosis, Recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000273949 | SCV000373329 | uncertain significance | Neuronal Ceroid-Lipofuscinosis, Recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000675461 | SCV001863097 | benign | not provided | 2019-08-15 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000675461 | SCV000801146 | benign | not provided | 2015-10-22 | no assertion criteria provided | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000675461 | SCV001798150 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001702419 | SCV001929822 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001702419 | SCV001966184 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001835777 | SCV002094846 | benign | Neuronal ceroid lipofuscinosis 2 | 2019-09-25 | no assertion criteria provided | clinical testing |